Stempoint Capital LP owned approximately 1.90% of Whitehawk Therapeutics worth $3,241,000 as of its most recent SEC filing. Quadrature Capital Ltd bought a new position in Whitehawk Therapeutics in the 4th quarter worth about $28,000. Dimensional Fund Advisors LP bought a new stake in Whitehawk Therapeutics during the 3rd quarter valued at about $84,000. Get Whitehawk Therapeutics alerts:Whitehawk Therapeutics Stock PerformanceWHWK opened at $3.66 on Thursday. Receive News & Ratings for Whitehawk Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Whitehawk Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.